Discovery and Development of Anti-Prostate Cancerous Agents from Natural Products

Herausgeber: Brahmachari, Goutam

• Broschiertes Buch

Produktbeschreibung

Discovery and Development of Anti-Prostate Cancer Agents from Natural Products presents cutting-edge research advances in the field of bioactive natural products and natural drug formulations. This new volume in the Natural Products Drug Discovery series focuses on molecules of natural origin and their synthetic analogues that show promising potential to act as anti-prostate cancer and chemotherapeutic agents. Combining foundational background information on cancer mechanisms with details of medicinal structures from natural products, this volume compiles the latest developments from across interdisciplinary fields. It will serve as a valuable resource for researchers working to discover promising leads for the development of novel pharmaceuticals for prostate cancer, highlighting several key structures from natural products and exploring possible future developments in the area.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Elsevier Science
• Seitenzahl: 500
• Erscheinungstermin: 1. Februar 2025
• Englisch
• ISBN-13: 9780443218422
• ISBN-10: 0443218420
• Artikelnr.: 70983891

Inhaltsangabe

1. Discovery and development of anti-prostate cancer agents from natural
products: an overview
2. Cannabinoids and prostate cancer
3. Flavones and prostate cancer
4. A brief sketch on anti-prostate cancer activity of plant phenolics
5. Anti-prostate cancer potential of some alkaloids
6. Prostate cancer and tomato lycopene
7. Medicinal plants from the Mediterranean basin as a source of natural
anti-prostate cancer agents
8. Withanolides as anti-prostate cancer agents of promise
9. Triterpenes as new promising anti-prostate cancer agents
10. Nanocarrier-mediated targeted delivery of natural products for prostate
cancer
11. The olive oil phenolic (-)-oleocanthal as a novel nutraceutical for
prostate cancer progression and recurrence control